HIV-associated neurocognitive disorder (HAND) has been associated with elevated inflammatory markers in the peripheral blood and cerebrospinal fluid (CSF) in chronic HIV. We investigated the dynamics of viral load and inflammatory markers in CSF and plasma during acute HIV infection and their impact on longitudinal neurocognitive performance (NP) after antiretroviral therapy (ART) in Peru.
MSM and transgender women in the Sabes study were followed with monthly testing (HIV Ab & RNA) and enrolled within 3 months of HIV acquisition. In ART-naïve HIV+ participants, 39 inflammatory markers were measured in plasma (N = 87) and 37 in CSF (N = 29) at enrollment. Time from infection to enrollment (ITE) was estimated by an algorithm using testing history (type, date and result of test). NP was assessed with a 15-test battery, averaged as a total Z score derived from Peruvian normative data and administered every 24 weeks. Linear regression was used to evaluate associations between VL, biomarkers, and ITE. In a subset analysis of 42 participants who started ART at enrollment, 13 of whom provided CSF samples, biomarker levels were used as predictors of change in standardized NP score from baseline (NP). We adjusted for multiple comparisons with the Benjamini-Hochberg (BH) method.
Longer ITE was associated with lower VL in CSF (β = -0.024 log10 copies/mm3/day, p = 0.03) and plasma, (β = -0.037 log10 copies/mm3/day, p = <0.0001). In univariate analysis, longer ITE was associated with lower levels of 24 and higher levels of 4 biomarkers. After adjustment with BH, ITE was negatively associated with baseline levels of VCAM-1, and IFN-y in both plasma and CSF, negatively associated with CSF CD-163 and positively associated with plasma CD-163. In the unadjusted subset analysis, higher levels of the following biomarkers predicted a negative NP at 2 time points: plasma YKL40; plasma and CSF IL-16, plasma IL-6, CSF TNF-β, CSF IL-16, CSF TNF- α, and CSF IP-10.
Higher baseline values of key inflammatory biomarkers in plasma and CSF in early HIV were correlated with greater reductions in NP score over time after ART. There was also a novel pattern of CSF and plasma inflammatory marker dynamics observed in the first two months of untreated HIV infection. Additional investigation of inflammatory events during acute HIV infection could offer key information on longitudinal neurological outcomes.